Clinerion’s Patient Network Explorer offers trial data to global sites
Clinerion’s Patient Network Explorer has added a new, actionable functionality that offers support to clinical...
Read More...
Focus:
Switzerland
-
![covid-19]()
NIH and Novartis stop hydroxychloroquine’s Covid-19 trials
The National Institutes of Health (NIH) in the US has suspended a clinical trial being...
Read More...
-
![Actemra trial]()
Roche begins trial of Actemra plus remdesivir to treat Covid-19
Roche has started a Phase III clinical trial to assess its Actemra/RoActemra in combination with...
Read More...
-
![Covid]()
WHO halts hydroxychloroquine Covid-19 trial over safety concerns
The World Health Organization (WHO) has temporarily suspended a clinical trial of the malaria drug...
Read More...
-
![satralizumab]()
Roche reports additional safety data of satralizumab in NMOSD
Roche has reported new pooled safety data of its satralizumab drug to treat patients suffering...
Read More...
-
![covid-19 treatment]()
A closer look at Takeda’s blood-based alternative to a Covid-19 vaccine
Takeda first announced it would be using its expertise in plasma-derived therapies to develop a...
Read More...
-
![Canakinumab]()
Novartis to trial canakinumab to treat Covid-19 pneumonia
Novartis has plans to conduct a Phase III clinical trial to assess canakinumab (Ilaris) for...
Read More...
-
![Jakavi]()
Novartis’ Jakavi yields positive data in GvHD patients
Novartis has reported positive data from the Phase III REACH2 clinical trial of Jakavi (ruxolitinib)...
Read More...
-
![daridorexant]()
Idorsia’s insomnia drug daridorexant passes Phase III study
Switzerland-based Idorsia has reported positive top-line data from the Phase III clinical trial of daridorexant...
Read More...
-
![gimsilumab]()
Roivant starts gimsilumab dosing in Covid-19 trial
Roivant Sciences has dosed the first participant in the BREATHE clinical trial of monoclonal antibody...
Read More...
